Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/15102
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMEBIS, Jeroen-
dc.date.accessioned2013-04-24T11:28:54Z-
dc.date.available2013-04-24T11:28:54Z-
dc.date.issued2012-
dc.identifier.citationESMO conference 2012, Vienna - Austria, 28/09 - 02/10/2012-
dc.identifier.urihttp://hdl.handle.net/1942/15102-
dc.language.isoen-
dc.titleWill ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?-
dc.typeConference Material-
local.bibliographicCitation.conferencedate2012, September 28-October 2-
local.bibliographicCitation.conferencenameESMO conference 2012-
local.bibliographicCitation.conferenceplaceVienna - Austria-
local.bibliographicCitation.jcatC2-
local.type.refereedRefereed-
local.type.specifiedConference Poster-
item.fullcitationMEBIS, Jeroen (2012) Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?. In: ESMO conference 2012, Vienna - Austria, 28/09 - 02/10/2012.-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.contributorMEBIS, Jeroen-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1386.pdfConference material105.38 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.